Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis: Part 2: Practical aspects of application;Wirkmechanismen nasaler Glukokortikosteroide in der Therapie der allergischen Rhinitis: Teil 2: Praxisorientierte Aspekte der Anwendung

HNO

Volumn 60, Issue 8, 2012, Pages 700-706

  von Bernus, L ^a   Hogger P ^b   Pfaar, O ^a   Klimek, L ^a  

^a ZENTRUM FÜR RHINOLOGIE UND ALLERGOLOGIE   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Allergic rhinitis; Forkhead box P3 protein, human; Mucosal inflammation; Nasal glucocorticosteroids; Regulatory T cells

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; GLUCOCORTICOID;

ARTICLE; BIOLOGICAL MODEL; HAY FEVER; HUMAN; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; TH2 CELL;

ADMINISTRATION, INTRANASAL; ANTI-INFLAMMATORY AGENTS; CYTOKINES; GLUCOCORTICOIDS; HUMANS; MODELS, IMMUNOLOGICAL; RHINITIS, ALLERGIC, SEASONAL; TH2 CELLS;

EID: 84865421252     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-012-2484-3     Document Type: Article

References (33)

1. Klimek L, Schendzielorz P, Högger P (2010) Nasale Glukokortikosteroid-Therapie: Ein Update. Allergologie 34(6):307-318.
2. Schäfer T, Schnoor M, Wagenmann M et al (2011) Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis. Rhinology 49(3):272-280.
3. + CD25high regulatory T cells in pediatric asthma. J Allergy Clin Immunol 119:1258-1266.
4. Li HB, Cai KM, Liu Z et al (2008) T regulatory cells (Tregs) are increased in nasal polyps (NP) after treatment with intranasal steroid. Clin Immunol 129:394-400.
5. + T regulatory cell in vivo and enhances their capacity to suppress EAE. Eur J Immunol 36:2139-2149.
6. Benninger MS, Ahmad N, Marple BF (2003) The safety of intranasal steroids. Otolaryngol Head Neck Surg 129:739-750.
7. Allen DB, Melzer EO, Lemanske RF Jr et al (2002) No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc 23:407-413.
8. Schenkel EJ, Skoner DP, Bronsky EA et al (2000) Ab-sence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 105:e22.
9. Daley-Yates PT, Kunka RL, Yin Y et al (2004) Bioavailability of flutiasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol 60:265-268.
10. Okubo K, Nakashima M, Miyake N et al (2009) Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis. Allergy Asthma Proc 30:84-94.
11. Brooks CD, Karl KJ, Francom SF (1993) Oral methylprednisolone acetate (Medrol tablets) for seasonal allergic rhinitis: examination of dose and symptom response. J Clin Pharmacol 33:816-822.
12. Vargas R, Dockhorn RJ, Findlay SR et al (1998) Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol 102:191-197.
13. Mygind N, Laursen LC, Dahl M (2000) Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Allergy 55:11-15.
14. Brozek JL, Bousquet J, Baena-Cagnani CE et al. (2010) Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 126(3):466-476.
15. Bernstein DI, Levy AL, Hampel FC et al (2004) Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 34:952-957.
16. Fokkens WJ, Jogi R, Reinartz S et al (2007) Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 62:1078-1084.
17. Baroody FM, Foster KA, Markaryan A et al (2008) Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol 100:194-199.
18. Kremer B, Hartog HM den, Jolles J (2002) Relationship between allergic rhinitis, disturbed cognitive functions and psychological wellbeing. Clin Exp Allergy 32:1310-1315.
19. Walker S, Khan-Wasti S, Fletcher M et al (2007) Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 120:381-387.
20. Young T, Finn L, Kim H (1997) Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wilcoxon Sleep and Respiratory Research Group. J Allergy Clin Immunol 99:757-762.
21. Vuurman EPF, Veggel LMA van, Uiterwijk MMC et al (1993) Seasonal allergic rhinitis and anti-histamine effect on children's learning. Ann Allergy 71:121-126.
22. Craig TJ, Hanks CD, Fisher LH (2005) How do topical nasal corticoids improve sleep and daytime somnolence in allergic rhinitis? J Allergy Clin Immunol 116:1264-1266.
23. Mansfield LE, Posey CR (2007) Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticosone propionate. Allergy Asthma Proc 28:226-229.
24. Kawauchi H (2004) Medication for allergic rhinitis. Otolaryngol Head Neck Surg 76:39-44.
25. Graft D, Aaronson D, Chervinsky P et al (1996) A placeboand active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol 98:724-731.
26. Okubo K, Nagakura T, Usui H et al (2005) Evaluation of efficacy, safety and effects on rhinitis-specific QOL by fluticasone propionate in pediatric patients with seasonal allergic rhinitis. Allergol Immunol 12:318-331.
27. Pascual G, Glass CK (2006) Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol Metab 17:321-327.
28. Saito M, Takayanagi R, Goto K et al. (2002) The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study. Mol Endocrinol 16:694-706.
29. Adcock IM, Ito K, Barnes PJ (2004) Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 1:247-254.
30. Navarro A, Valero A, Rosales MJ, Mullol J (2011) Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis. J Investg Allergol Clin Immunol 21(5):363-369.
31. Cheng CC, Baroody FM, Reed KC et al (1997) Effects of one year treatment with fluticasone propionate aqueous nasal spray (FPANS) and terfenadine (TER) on the nasal mucosa: I. A safety study using electron and light microscopy. J Allergy Clin Immunol 99:2013-2013.
32. Pipkorn U, Pukander J, Suonpaa J et al (1988) Long-term safety of budesonide nasal aerosol - a 5.5 year follow up study. Clin Allergy 18:253-259.
33. Rachelefsky GS, Chervinsky P, Meltzer EO et al (1998) An evaluation of the effects of beclomethasone diproprionate on long-term growth in children. J Allergy Clin Immunol 101:236.